Two red lines were all it took to confirm what 26-year-old Luke Galade (not his real name) had already prepared himself for.

Anuradhapura Divisional Health Services Deputy Director Dr. Dhammika De Silva said that anti-HIV programme in the ...

Peter Redweik’s brutal infection was quelled by a medication so powerful that doctors use it sparingly. Yet he continued to ...

And another study says people with HIV are too often excluded from cancer trials.  And another study says people with HIV are ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

The Affordable Care Act will continue to provide free preventative medications to millions of people who rely on that ...

If the ’80s and ’90s taught us anything, it’s that you’ll never win if you don’t play. it may be time to indeed "Act Up" ...

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight ...

Global health advocates are concerned that the U.S. is halting support for the the Gavi program that immunized roughly 1.1 ...

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

As the federal government moves forward with steep cuts to medical and research funding, some in the Bay Area who depend on ...

The Australian researchers developed a novel mRNA-based technology capable of reaching the white blood cells where HIV lies ...